Skip to content
10-K

Annual Report

Edgewise Therapeutics, Inc. EWTX

0001104659-26-020112

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 19, 2026 107.27M sh
Shares Diluted FY 2025 · Dec 31, 2025 102.93M sh
Shares Diluted FY 2025 · Dec 31, 2024 92.41M sh
Shares Diluted FY 2025 · Dec 31, 2023 63.72M sh
Capex FY 2025 · Dec 31, 2025 $256K
Capex FY 2025 · Dec 31, 2024 $1.31M
Capex FY 2025 · Dec 31, 2023 $5.75M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$143.82M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$109.03M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$91.95M
Cash And Equivalents FY 2025 · Dec 31, 2025 $61.15M
Cash And Equivalents FY 2025 · Dec 31, 2024 $41.67M
Stockholders Equity FY 2025 · Dec 31, 2025 $522.26M
Stockholders Equity FY 2025 · Dec 31, 2024 $459.22M
Stockholders Equity FY 2025 · Dec 31, 2023 $318.83M
Stockholders Equity FY 2025 · Dec 31, 2022 $346.72M
Current Liabilities FY 2025 · Dec 31, 2025 $27.37M
Current Liabilities FY 2025 · Dec 31, 2024 $23.86M
Total Liabilities FY 2025 · Dec 31, 2025 $30.35M
Total Liabilities FY 2025 · Dec 31, 2024 $27.6M
Current Assets FY 2025 · Dec 31, 2025 $543.39M
Current Assets FY 2025 · Dec 31, 2024 $475.48M
Total Assets FY 2025 · Dec 31, 2025 $552.6M
Total Assets FY 2025 · Dec 31, 2024 $486.82M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.63
Eps Diluted FY 2025 · Dec 31, 2024 −$1.45
Eps Diluted FY 2025 · Dec 31, 2023 −$1.57
Eps Basic FY 2025 · Dec 31, 2025 −$1.63
Eps Basic FY 2025 · Dec 31, 2024 −$1.45
Eps Basic FY 2025 · Dec 31, 2023 −$1.57
Sga Expense FY 2025 · Dec 31, 2025 $40.02M
Sga Expense FY 2025 · Dec 31, 2024 $31.87M
Sga Expense FY 2025 · Dec 31, 2023 $23.45M
Rd Expense FY 2025 · Dec 31, 2025 $151.39M
Rd Expense FY 2025 · Dec 31, 2024 $126.97M
Rd Expense FY 2025 · Dec 31, 2023 $90.91M
Net Income FY 2025 · Dec 31, 2025 −$167.8M
Net Income FY 2025 · Dec 31, 2024 −$133.81M
Net Income FY 2025 · Dec 31, 2023 −$100.16M
Operating Income FY 2025 · Dec 31, 2025 −$191.41M
Operating Income FY 2025 · Dec 31, 2024 −$158.83M
Operating Income FY 2025 · Dec 31, 2023 −$114.36M
Stock Issued FY 2025 · Apr 3, 2025 9.94M sh